HOME › DRUGS › TENECTEPLASE
ACTIVE SUBSTANCE / INN

TENECTEPLASE

Brand name(s): Metalyse, Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KG, TNKASE
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
AUTHORISED
Myocardial Infarction
BLA103909
ACTIVE SUBSTANCE
Tenecteplase
REGULATORS
FDA · EMA
SPONSORS / MAH
GENENTECH, Boehringer Ingelheim International GmbH
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TNKASEBLA103909GENENTECHPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MetalyseBoehringer Ingelheim International GmbHAuthorised23/02/2001Myocardial Infarction
Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KGBoehringer Ingelheim International GmbHWithdrawn23/02/2001Myocardial Infarction

FULL INTELLIGENCE ON TENECTEPLASE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →